
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT Hepatic complications of transplant are a common cause of mortality. Although mild elevations of serum aminotransferase enzymes (aspartate and alanine (AST, ALT)) do not carry an
adverse prognosis, this is not the case with severe hepatocellular injury. We reviewed 6225 consecutive recipients to determine the incidence and outcomes of severe hepatocellular injury
(AST >1500 U/l) before day 100, which occurred in 88 patients. Causes were sinusoidal obstruction syndrome (SOS) (_n_=46), hypoxic hepatitis (_n_=33), varicella zoster virus (VZV)
hepatitis (_n_=4), drug-liver injury (_n_=2) and unknown (_n_=3). The incidence declined from 1.9% in the 1990s to 1.1% recently (owing to a fivefold decline in SOS and disappearance of VZV
hepatitis). In hypoxic hepatitis, peak serum AST was 3545 U/l (range, 1380–25 246) within days of shock or prolonged hypoxemia; case fatality rate was 88%. In SOS, AST increases occurred 2–6
weeks after diagnosis; peak AST was 2252 U/l (range, 1437–8281); case fatality rate was 76%, with only serum bilirubin able to distinguish survivors (2.7 vs 11.3 mg/100 ml, _P_=0.0009). We
conclude that circulatory insults (sinusoidal injury, hypotension and hypoxemia), and not infection, are the most common cause of severe hepatocellular injury, the frequency of which has
declined because of a falling incidence of SOS and VZV hepatitis. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution
ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article *
Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn
about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS ACUTE KIDNEY INJURY WITHIN 100 DAYS POST ALLOGENEIC HEMATOPOIETIC CELL
TRANSPLANTATION IS ASSOCIATED WITH INCREASED RISK OF POST-TRANSPLANT COMPLICATIONS AND POOR TRANSPLANT OUTCOMES Article 25 June 2022 LOW INCIDENCE OF HEPATIC SINUSOIDAL OBSTRUCTION
SYNDROME/VENO-OCCLUSIVE DISEASE IN ADULTS UNDERGOING ALLOGENIC STEM CELL TRANSPLANTATION WITH PROPHYLACTIC URSODIOL AND LOW-DOSE HEPARIN Article Open access 04 January 2022 UTILITY OF THE
REFINED EBMT DIAGNOSTIC AND SEVERITY CRITERIA 2023 FOR SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE Article Open access 29 January 2024 REFERENCES * Strasser SI, McDonald GB .
Gastrointestinal and hepatic complications. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG (eds). _Thomas' Hematopoietic Cell Transplantation_, 4th edn. Wiley-Blackwell Publishing:
Oxford, UK, 2009, pp 1434–1455. Chapter Google Scholar * Gooley TA, Rajvanshi P, Schoch HG, McDonald GB . Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic
cell transplantation. _Hepatology_ 2005; 41: 345–352. Article CAS PubMed Google Scholar * El-Sayed MH, El-Haddad A, Fahmy OA, Salama II, Mahmoud HK . Liver disease is a major cause of
mortality following allogeneic bone-marrow transplantation. _Eur J Gastroenterol Hepatol_ 2004; 16: 1347–1354. Article PubMed Google Scholar * Kim B, Chung K, Sun H, Suh J, Min W, Kang C
_et al_. Liver disease during the first posttransplant year in bone marrow transplantation recipients: retrospective study. _Bone Marrow Transplant_ 2000; 26: 193–197. Article CAS PubMed
Google Scholar * McDonald GB . Management of hepatic disease following hematopoietic cell transplant. _Alimentary Pharmacol Ther_ 2006; 24: 441–452. Article CAS Google Scholar * Shulman
HM, McDonald GB . Hepatic complications of hematopoietic cell transplantation. In: Gershwin ME, Vierling JM, Manns M (eds). _Liver Immunology: Principles and Practice_. Humana Press: Totowa,
NJ, 2007, pp 409–421. Chapter Google Scholar * Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG _et al_. Hepatitis C virus infection after bone marrow
transplantation: a cohort study with 10 year follow-up. _Hepatology_ 1999; 29: 1893–1899. Article CAS PubMed Google Scholar * Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger
M _et al_. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. _Blood_ 2002; 100: 1977–1983. Article CAS PubMed Google Scholar * Ho
G-T, Parker A, MacKenzie JF, Morris AJ, Stanley AJ . Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. _Eur J Gastroenterol Hepatol_
2004; 16: 157–162. Article PubMed Google Scholar * Sucak G, Yegin Z, Ozkurt Z, Aki S, Karakan T, Akyol G . The role of liver biopsy in the workup of liver dysfunction late after SCT: is
the role of iron overload underestimated? _Bone Marrow Transplant_ 2008; 42: 461–467. Article CAS PubMed Google Scholar * Lau GKK, Strasser SI, McDonald GB . Hepatitis virus infections
in patients with cancer. In: Wingard JR, Bowden RA (eds). _Management of Infection in Oncology Patients_. Martin Dunitz: London, UK, 2003, pp 321–342. Chapter Google Scholar * Henrion J,
Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR . Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. _Medicine_ 2003; 82: 392–406. Article PubMed Google
Scholar * Deleve LD, Shulman HM, McDonald GB . Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venocclusive disease). _Semin Liver Dis_ 2002; 22: 27–41. Article PubMed
Google Scholar * Kaplowitz N, DeLeve LD (eds). _Drug Induced Liver Disease_, 2nd edn. Informa Healthcare USA, Inc.: New York, 2007. Book Google Scholar * Strasser SI, Shulman HM,
McDonald GB . Cholestasis after hematopoietic cell transplantation. _Clin Liver Dis_ 1999; 3: 651–668. Article CAS PubMed Google Scholar * Rossi MR, Longoni DV, Rovelli AM, Uderzo C .
Severe rhabdomyolysis, hyperthermia and shock after amphotericin B colloidal dispersion in an allogeneic bone marrow transplant recipient. _Pediatr Infect Dis J_ 2000; 19: 172–173. Article
CAS PubMed Google Scholar * Tong J, Laport G, Lowsky R . Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma. _Bone Marrow
Transplant_ 2005; 36: 739–740. Article CAS PubMed Google Scholar * Rajvanshi P, Shulman HM, Sievers EL, McDonald GB . Hepatic sinusoidal obstruction following Gemtuzumab ozogamicin
(Mylotarg) therapy. _Blood_ 2002; 99: 4245–4246. Article Google Scholar * McDonald GB, Hinds MS, Fisher LB, Schoch HG, Wolford JL, Banaji M _et al_. Venocclusive disease of the liver and
multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. _Ann Intern Med_ 1993; 118: 255–267. Article CAS PubMed Google Scholar * Fischer MA, Winkelmayer WC,
Rubin RH, Avorn J . The hepatotoxicity of antifungal medications in bone marrow transplant recipients. _Clin Infect Dis_ 2005; 41: 301–307. Article CAS PubMed Google Scholar * Honjo I,
Suou T, Hirayama C . Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis. _Res Commun Chem Pathol Pharmacol_ 1988; 61: 149–165. CAS PubMed Google Scholar * Gnann J .
Herpes simplex and varicella zoster virus infection after hemopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV (eds). _Transplant Infections_. 2nd edn.
Lippincott Williams and Wilkins: Philadelphia, 2003, pp 350–366. Google Scholar * Shields AF, Hackman RC, Fife KH, Corey L, Meyer JD . Adenovirus infections in patients undergoing bone
marrow transplantation. _N Engl J Med_ 1985; 312: 529–533. Article CAS PubMed Google Scholar * Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A _et al_. Treatment of
adenovirus disease in stem cell transplant recipients with cidofovir. _Biol Blood Marrow Transplant_ 2007; 13: 74–81. Article CAS PubMed Google Scholar * Wang WH, Wang HL . Fulminant
adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature. _Arch Pathol Lab Med_ 2003; 127: e246–e248. PubMed Google Scholar * Strasser
SI, Shulman HM, Flowers ME, Reddy R, Margolis DA, Prumbaum M _et al_. Chronic graft-vs-host disease of the liver: presentation as an acute hepatitis. _Hepatology_ 2000; 32: 1265–1271.
Article CAS PubMed Google Scholar * Akpek G, Boitnott JK, Lee LA, Hallick JP, Torbenson M, Jacobsohn DA _et al_. Hepatitic variant of graft-versus-host disease after donor lymphocyte
infusion. _Blood_ 2002; 100: 3903–3907. Article CAS PubMed Google Scholar * Sakai M, McDonald GB . Gastrointestinal and hepatic manifestations of chronic GVHD. In: Vogelsang G, Pavletic
S (eds). _Chronic Graft-Versus-Host Disease: Interdisciplinary Management_. Cambridge University Press: New York, NY, 2009, pp 216–228. Chapter Google Scholar * Shulman HM, Fisher LB,
Schoch HG, Henne KW, McDonald GB . Venocclusive disease of the liver after marrow transplantation: histologic correlates of clinical signs and symptoms. _Hepatology_ 1994; 19: 1171–1180.
Article CAS PubMed Google Scholar * Traber PG, Chianale J, Gumucio JJ . Physiologic significance and regulation of hepatocellular heterogeneity. _Gastroenterology_ 1988; 95: 1130–1143.
Article CAS PubMed Google Scholar * McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM _et al_. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS):
an overview from the research on adverse drug events and reports (RADAR) project. _Leuk Res_ 2007; 31: 599–604. Article CAS PubMed Google Scholar * McDonald GB, Frieze D . A
problem-oriented approach to liver disease in oncology patients. _Gut_ 2008; 57: 987–1003. Article CAS PubMed Google Scholar * McDonald GB, Schoch H, Gooley T . Liver complications of
allogeneic hematopoietic cell transplant: declining incidence related to changes in practice (Abstract). _Hepatology_ 2008; 48 (Suppl): 318A–319A. Google Scholar Download references
ACKNOWLEDGEMENTS Our research in the field of gastrointestinal and hepatobiliary complications of hematopoietic cell transplant is supported by grants from the US National Institutes of
Health, National Cancer Institute (CA 18029, CA 15704). Dr Sakai is supported by funding from the Bureau of Social Welfare and Public Health of the Tokyo Metropolitan Government and the
Japan Clinical Research Support Unit. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA M Sakai, H M Shulman,
S J McDonald, H G Schoch & G B McDonald * AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia S I Strasser * Department of
Medicine, University of Washington School of Medicine, Seattle, WA, USA H M Shulman & G B McDonald Authors * M Sakai View author publications You can also search for this author inPubMed
Google Scholar * S I Strasser View author publications You can also search for this author inPubMed Google Scholar * H M Shulman View author publications You can also search for this author
inPubMed Google Scholar * S J McDonald View author publications You can also search for this author inPubMed Google Scholar * H G Schoch View author publications You can also search for
this author inPubMed Google Scholar * G B McDonald View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT
THIS ARTICLE CITE THIS ARTICLE Sakai, M., Strasser, S., Shulman, H. _et al._ Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome. _Bone Marrow
Transplant_ 44, 441–447 (2009). https://doi.org/10.1038/bmt.2009.56 Download citation * Received: 07 November 2008 * Revised: 29 January 2009 * Accepted: 07 February 2009 * Published: 23
March 2009 * Issue Date: October 2009 * DOI: https://doi.org/10.1038/bmt.2009.56 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable
link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * hepatocellular
injury * sinusoidal obstruction syndrome * viral hepatitis * hematopoietic cell transplant * hypoxic hepatitis * outcomes